Castleark Management LLC Vertex Pharmaceuticals Inc Transaction History
Castleark Management LLC
- $2.41 Billion
- Q3 2024
A detailed history of Castleark Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Castleark Management LLC holds 82,725 shares of VRTX stock, worth $34.9 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
82,725
Previous 46,803
76.75%
Holding current value
$34.9 Million
Previous $21.9 Million
75.38%
% of portfolio
1.6%
Previous 0.91%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,718Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11.3 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.77 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.99 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.99 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.8 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $108B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...